SMART Wealth LLC Has $349,000 Stock Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

SMART Wealth LLC raised its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 13.4% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 669 shares of the medical equipment provider’s stock after acquiring an additional 79 shares during the quarter. SMART Wealth LLC’s holdings in Intuitive Surgical were worth $349,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors also recently modified their holdings of ISRG. Bennett Selby Investments LP raised its position in Intuitive Surgical by 3.9% in the 4th quarter. Bennett Selby Investments LP now owns 449 shares of the medical equipment provider’s stock worth $234,000 after purchasing an additional 17 shares during the last quarter. LVW Advisors LLC raised its position in shares of Intuitive Surgical by 1.3% during the fourth quarter. LVW Advisors LLC now owns 1,448 shares of the medical equipment provider’s stock worth $756,000 after acquiring an additional 19 shares during the last quarter. Wesbanco Bank Inc. lifted its stake in shares of Intuitive Surgical by 1.6% during the fourth quarter. Wesbanco Bank Inc. now owns 1,216 shares of the medical equipment provider’s stock valued at $635,000 after acquiring an additional 19 shares during the period. FSM Wealth Advisors LLC increased its position in Intuitive Surgical by 3.7% in the fourth quarter. FSM Wealth Advisors LLC now owns 526 shares of the medical equipment provider’s stock worth $275,000 after purchasing an additional 19 shares during the period. Finally, Journey Strategic Wealth LLC increased its position in Intuitive Surgical by 1.9% in the fourth quarter. Journey Strategic Wealth LLC now owns 1,039 shares of the medical equipment provider’s stock worth $542,000 after purchasing an additional 19 shares during the period. 83.64% of the stock is owned by institutional investors.

Insider Buying and Selling

In other news, insider Jamie Samath sold 269 shares of the business’s stock in a transaction on Monday, November 11th. The shares were sold at an average price of $539.89, for a total value of $145,230.41. Following the sale, the insider now owns 8,757 shares of the company’s stock, valued at $4,727,816.73. The trade was a 2.98 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, EVP Robert Desantis sold 376 shares of the firm’s stock in a transaction on Friday, November 29th. The shares were sold at an average price of $539.00, for a total transaction of $202,664.00. Following the completion of the transaction, the executive vice president now directly owns 5,506 shares of the company’s stock, valued at approximately $2,967,734. This trade represents a 6.39 % decrease in their position. The disclosure for this sale can be found here. In the last ninety days, insiders sold 5,940 shares of company stock valued at $3,333,485. Company insiders own 0.80% of the company’s stock.

Intuitive Surgical Stock Down 0.4 %

Intuitive Surgical stock opened at $588.50 on Friday. Intuitive Surgical, Inc. has a twelve month low of $364.17 and a twelve month high of $616.00. The company has a 50 day moving average of $553.03 and a 200-day moving average of $512.59. The stock has a market capitalization of $209.61 billion, a PE ratio of 91.81, a price-to-earnings-growth ratio of 5.51 and a beta of 1.39.

Analysts Set New Price Targets

Several brokerages have recently issued reports on ISRG. Citigroup raised their target price on shares of Intuitive Surgical from $640.00 to $711.00 and gave the company a “buy” rating in a research note on Friday, January 24th. Barclays raised their price objective on shares of Intuitive Surgical from $610.00 to $674.00 in a research note on Monday, January 27th. The Goldman Sachs Group set a $604.00 target price on shares of Intuitive Surgical in a research report on Friday, October 18th. Oppenheimer restated a “market perform” rating on shares of Intuitive Surgical in a research report on Friday, October 18th. Finally, Bernstein Bank upped their price objective on Intuitive Surgical from $655.00 to $700.00 and gave the company an “overweight” rating in a report on Monday, January 27th. One analyst has rated the stock with a sell rating, five have given a hold rating and sixteen have issued a buy rating to the company’s stock. According to data from MarketBeat.com, Intuitive Surgical presently has an average rating of “Moderate Buy” and an average target price of $613.10.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.